title: Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity.
abstract: Creatine is a molecule that supports energy metabolism in cells. It is carried across the plasma membrane by the creatine transporter. There has been recent interest in creatine for its neuroprotective effects in neurodegenerative diseases and its potential as a therapeutic agent. This study represents the first systematic investigation of the distribution of the creatine transporter in the human brain. We have used immunohistochemical techniques to map out its location and the intensity of staining. The transporter was found to be strongly expressed, especially in the large projection neurons of the brain and spinal cord. These include the pyramidal neurons in the cerebral cortex, Purkinje cells in the cerebellar cortex, and motor neurons of the somatic motor and visceromotor cranial nerve nuclei and the ventral horn of the spinal cord. Many other neurons in the brain also had some degree of creatine transporter immunoreactivity. By contrast, the medium spiny neurons of the striatum and the catecholaminergic neurons of the substantia nigra and locus coeruleus, which are implicated in neurodegenerative diseases, showed a very low to almost absent level of immunoreactivity for the transporter. We propose that the distribution may reflect the energy consumption by different cell types and that the extent of creatine transporter expression is proportional to the cell's energy requirements. Furthermore, the distribution indicates that supplemented creatine would be widely taken up by brain cells, although possibly less by those cells that degenerate in Huntington's and Parkinson's diseases.
authors.affiliation: Centre for Brain Research and Department of Anatomy with Radiology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, 1142, New Zealand.
authors.forename: Matthew T J
authors.initials: MT
authors.lastname: Lowe
authors.forename: Richard L M
authors.initials: RL
authors.lastname: Faull
authors.forename: David L
authors.initials: DL
authors.lastname: Christie
authors.forename: Henry J
authors.initials: HJ
authors.lastname: Waldvogel
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015153:Blotting, Western; D001921:Brain / Q000378:metabolism*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D026901:Membrane Transport Proteins / Q000378:metabolism*; D008875:Middle Aged; D009474:Neurons / Q000378:metabolism; D013116:Spinal Cord / Q000378:metabolism
chemical_list: D026901:Membrane Transport Proteins; C080679:creatine transporter
keywords: AB_10000342; AB_10000343; AB_10000347; AB_10123643; AB_2114471; AB_2157554; AB_2224402; AB_477010; AB_887872; neurodegeneration; neuroenergetics; phosphocreatine